ABArun Bahulikar

Arun Bahulikar

*This is an algorithmically generated author record based on publicly available information.

Arun Bahulikar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic and Prognostic Value of Presepsin in Sepsis: A Prospective Observational Study

    by Abhishek Nimbal, Arun Bahulikar, Deepak Phalgune, Ajit Tambolkar

    Presepsin is hypothesized to be more specific for the diagnosis of sepsis, as it is directly involved in the pathogenesis of the syndrome. Several studies have investigated the clinical validity of presepsin; however, the results have shown considerable variability. The present study aimed to determine the diagnostic accuracy of presepsin as a biomarker for the diagnosis of sepsis. This prospective observational study included 140 patients, aged 18 years and older, who presented with suspected sepsis, a quick sequential organ failure assessment (qSOFA) score ≥2, and radiological or microbiological evidence of infection. The study was conducted from April 2024 to February 2025 at a tertiary care hospital in Western India. The SOFA score and presepsin levels were measured at the time of presentation. Receiver-operating characteristic (ROC) curve analysis was performed to determine the optimal presepsin cutoff value for predicting sepsis and mortality. Presepsin levels were significantly higher in patients with sepsis and in those who died. They showed a strong correlation with the SOFA score (r = 0.45; p = 0.01). Receiver-operating characteristic analysis demonstrated that presepsin is a strong predictor of sepsis [area under the curve (AUC) = 0.926 (95% CI: 0.881–0.971; cutoff > 195 pg/mL; sensitivity, 87.2%; specificity, 88.9%]. For mortality, ROC analysis showed good predictive value [AUC = 0.843 (95% CI: 0.755–0.931); cutoff > 1,364 pg/mL; sensitivity, 78.0%; specificity, 80.0%]. Presepsin is a reliable biomarker for the diagnosis and prognosis of sepsis. Nimbal A, Bahulikar A, Phalgune D, Tambolkar A. Diagnostic and Prognostic Value of Presepsin in Sepsis: A Prospective Observational Study. Indian J Crit Care Med 2026;30(2):117–121.

  • Open Access

    Validity of Blood Urea Nitrogen to Serum Albumin Ratio as an Independent Biomarker to Predict Severity and Mortality of Community-acquired Pneumonia

    by Vihita Kulkarni, Arun Bahulikar, Deepak Phalgune, Sanjay Pujari, Abdeali Ginwala

    Certain serum biomarkers have been reported to predict the severity and mortality of community-acquired pneumonia (CAP). There is a dearth of studies on this subject in the Indian population in patients with CAP. The present prospective observational study was conducted to find the utility of the blood urea nitrogen (BUN)/serum albumin (B/A) ratio as a biomarker to predict the severity and mortality in patients with CAP. All 90 patients aged ≥ 18 years of either sex, with a new radiographic infiltrate, were included. Various biochemical parameters such as BUN, serum albumin, and procalcitonin were tested. The serum B/A ratio was calculated. A chest radiograph was obtained. Patients were followed up for the duration of their stay in hospital till discharge or death. The sensitivity and specificity of the B/A ratio at the optimum cut-off value of 10.66 to predict the severity of CAP was about 79.0%, whereas the sensitivity and specificity of the procalcitonin at the optimum cut-off value of 1.50 ng/dL to predict the severity of CAP were 71.15 and 84.21%, respectively. The sensitivity and specificity of the B/A ratio at the optimum cut-off value of 19.8 to predict the mortality of CAP was about 99.0%, whereas the sensitivity and specificity of the procalcitonin at the optimum cut-off value of 5.55 ng/dL to predict the mortality of CAP was about 92.0%. The B/A ratio and procalcitonin are simple but independent predictors of mortality and severity of CAP. Ginwala A, Pujari S, Phalgune D, Kulkarni V, Bahulikar A. Validity of Blood Urea Nitrogen to Serum Albumin Ratio as an Independent Biomarker to Predict Severity and Mortality of Community-acquired Pneumonia. Indian J Crit Care Med 2025;29(4):333–337.